-
DATE OF BOARD MEETING2021-08-16
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 20212021-08-16
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 20212021-07-07
-
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS2021-06-28
-
ESTABLISHMENT OF THE ENVIRONMENTAL, SOCIAL AND GOVERNANCE COMMITTEE AND APPOINTMENT OF COMMITTEE MEMBERS2021-06-28
-
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF“TENOFOVIR AMIBUFENAMIDE TABLETS”2021-06-23
-
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF“LURASIDONE HYDROCHLORIDE TABLETS”2021-06-11
-
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL NOTICE OF“HS-10365 CAPSULES”2021-06-04
-
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF“ERLOTINIB HYDROCHLORIDE TABLETS”2021-06-04
-
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON THURSDAY, JUNE 3, 20212021-06-03
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 20212021-06-02
-
VOLUNTARY ANNOUNCEMENT - RESULTS OF THE PHASE III AENEAS STUDY OF AMEILE AS THE FIRST-LINE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC EGFR-MUTATED NON-SMALL CELL LUNG CANCER WILL BE PUBLISHED AT THE 2021 ASCO ANNUAL MEETING2021-05-20
